APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-device Clinical Decision Support Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-device Clinical Decision Support Software Market Outlook and Growth Opportunities 2026

2 May 2026192 pages

Choose your research edition.

Industry ResearchNon-device Clinical Decision Support Software Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-device Clinical Decision Support Software Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Non-device Clinical Decision Support Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-device Clinical Decision Support Software Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-device Clinical Decision Support Software Market Analysis and Forecast 2026-2032236 pages · $4,950 USD

Market perspective

The global Non-device Clinical Decision Support Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-device Clinical Decision Support Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-device Clinical Decision Support Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-device Clinical Decision Support Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-device Clinical Decision Support Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-device Clinical Decision Support Software market include Roche, Claricode, Philips Healthcare, Persivia, Cerner, Zynx Health, Elsevier, Epic and EPSi/Allscripts, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Non-device Clinical Decision Support Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-device Clinical Decision Support Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-device Clinical Decision Support Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Non-device Clinical Decision Support Software market.

Non-device Clinical Decision Support Software Segment by Company

Roche

Claricode

Philips Healthcare

Persivia

Cerner

Zynx Health

Elsevier

Epic

EPSi/Allscripts

Stanson Health

Cambio

Premier

Truven/IBM

NDSC/Change

MEDITECH

Non-device Clinical Decision Support Software Segment by Type

On-premises

Cloud

Non-device Clinical Decision Support Software Segment by Application

Drug Allergy Alerts

Drug Reminders

Drug-drug Interactions

Clinical

Non-device Clinical Decision Support Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-device Clinical Decision Support Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Non-device Clinical Decision Support Software key companies, revenue, market share, and recent developments.

3. To split the Non-device Clinical Decision Support Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Non-device Clinical Decision Support Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-device Clinical Decision Support Software significant trends, drivers, influence factors in global and regions.

6. To analyze Non-device Clinical Decision Support Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-device Clinical Decision Support Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-device Clinical Decision Support Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-device Clinical Decision Support Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-device Clinical Decision Support Software industry.

Chapter 3: Detailed analysis of Non-device Clinical Decision Support Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Non-device Clinical Decision Support Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Non-device Clinical Decision Support Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-device Clinical Decision Support Software Industry Trends Table 2. Non-device Clinical Decision Support Software Industry Drivers Table 3. Non-device Clinical Decision Support Software Industry Opportunities and Challenges Table 4. Non-device Clinical Decision Support Software Industry Restraints Table 5. Global Non-device Clinical Decision Support Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-device Clinical Decision Support Software Revenue Share by Company (2021-2026) Table 7. Global Non-device Clinical Decision Support Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Non-device Clinical Decision Support Software Key Company Manufacturing Base & Headquarters Table 9. Global Non-device Clinical Decision Support Software Company, Product Type & Application Table 10. Global Non-device Clinical Decision Support Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Non-device Clinical Decision Support Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-premises Table 15. Significant Companies of Cloud Table 16. Global Non-device Clinical Decision Support Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Non-device Clinical Decision Support Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Non-device Clinical Decision Support Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Non-device Clinical Decision Support Software Sales Value Share by Type (2021-2026) Table 20. Global Non-device Clinical Decision Support Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Drug Allergy Alerts Table 22. Significant Companies of Drug Reminders Table 23. Significant Companies of Drug-drug Interactions Table 24. Significant Companies of Clinical Table 25. Global Non-device Clinical Decision Support Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Non-device Clinical Decision Support Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Non-device Clinical Decision Support Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Non-device Clinical Decision Support Software Sales Value Share by Application (2021-2026) Table 29. Global Non-device Clinical Decision Support Software Sales Value Share by Application (2027-2032) Table 30. Global Non-device Clinical Decision Support Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Non-device Clinical Decision Support Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Non-device Clinical Decision Support Software Sales Value Share by Region (2021-2026) Table 33. Global Non-device Clinical Decision Support Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Non-device Clinical Decision Support Software Sales Value Share by Region (2027-2032) Table 35. Global Non-device Clinical Decision Support Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Non-device Clinical Decision Support Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Non-device Clinical Decision Support Software Sales Value Market Share by Country (2021-2026) Table 38. Global Non-device Clinical Decision Support Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Non-device Clinical Decision Support Software Sales Value Market Share by Country (2027-2032) Table 40. Roche Company Information Table 41. Roche Business Overview Table 42. Roche Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Roche Non-device Clinical Decision Support Software Product Portfolio Table 44. Roche Recent Development Table 45. Claricode Company Information Table 46. Claricode Business Overview Table 47. Claricode Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Claricode Non-device Clinical Decision Support Software Product Portfolio Table 49. Claricode Recent Development Table 50. Philips Healthcare Company Information Table 51. Philips Healthcare Business Overview Table 52. Philips Healthcare Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Philips Healthcare Non-device Clinical Decision Support Software Product Portfolio Table 54. Philips Healthcare Recent Development Table 55. Persivia Company Information Table 56. Persivia Business Overview Table 57. Persivia Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Persivia Non-device Clinical Decision Support Software Product Portfolio Table 59. Persivia Recent Development Table 60. Cerner Company Information Table 61. Cerner Business Overview Table 62. Cerner Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Cerner Non-device Clinical Decision Support Software Product Portfolio Table 64. Cerner Recent Development Table 65. Zynx Health Company Information Table 66. Zynx Health Business Overview Table 67. Zynx Health Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Zynx Health Non-device Clinical Decision Support Software Product Portfolio Table 69. Zynx Health Recent Development Table 70. Elsevier Company Information Table 71. Elsevier Business Overview Table 72. Elsevier Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Elsevier Non-device Clinical Decision Support Software Product Portfolio Table 74. Elsevier Recent Development Table 75. Epic Company Information Table 76. Epic Business Overview Table 77. Epic Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Epic Non-device Clinical Decision Support Software Product Portfolio Table 79. Epic Recent Development Table 80. EPSi/Allscripts Company Information Table 81. EPSi/Allscripts Business Overview Table 82. EPSi/Allscripts Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. EPSi/Allscripts Non-device Clinical Decision Support Software Product Portfolio Table 84. EPSi/Allscripts Recent Development Table 85. Stanson Health Company Information Table 86. Stanson Health Business Overview Table 87. Stanson Health Non-device Clinical Decision Support Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Stanson Health Non-device Clinical Decision Support Software Product Portfolio Table 89. Stanson Health Recent Development Table 90. Cambio Company Information Table 91. Cambio Business Overview Table 92. Cambio Non-device Clinical Decision Support Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Cambio Non-device Clinical Decision Support Software Product Portfolio Table 94. Cambio Recent Development Table 95. Premier Company Information Table 96. Premier Business Overview Table 97. Premier Non-device Clinical Decision Support Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Premier Non-device Clinical Decision Support Software Product Portfolio Table 99. Premier Recent Development Table 100. Truven/IBM Company Information Table 101. Truven/IBM Business Overview Table 102. Truven/IBM Non-device Clinical Decision Support Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Truven/IBM Non-device Clinical Decision Support Software Product Portfolio Table 104. Truven/IBM Recent Development Table 105. NDSC/Change Company Information Table 106. NDSC/Change Business Overview Table 107. NDSC/Change Non-device Clinical Decision Support Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. NDSC/Change Non-device Clinical Decision Support Software Product Portfolio Table 109. NDSC/Change Recent Development Table 110. MEDITECH Company Information Table 111. MEDITECH Business Overview Table 112. MEDITECH Non-device Clinical Decision Support Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. MEDITECH Non-device Clinical Decision Support Software Product Portfolio Table 114. MEDITECH Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Non-device Clinical Decision Support Software Product Image Figure 2. Global Non-device Clinical Decision Support Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-device Clinical Decision Support Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-device Clinical Decision Support Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-premises Image Figure 8. Cloud Image Figure 9. Global Non-device Clinical Decision Support Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Non-device Clinical Decision Support Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Non-device Clinical Decision Support Software Sales Value Share by Type (2021-2032) Figure 12. Drug Allergy Alerts Image Figure 13. Drug Reminders Image Figure 14. Drug-drug Interactions Image Figure 15. Clinical Image Figure 16. Global Non-device Clinical Decision Support Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Non-device Clinical Decision Support Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Non-device Clinical Decision Support Software Sales Value Share by Application (2021-2032) Figure 19. Global Non-device Clinical Decision Support Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Non-device Clinical Decision Support Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Non-device Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Non-device Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Non-device Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Non-device Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Non-device Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Non-device Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Non-device Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Non-device Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Non-device Clinical Decision Support Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Non-device Clinical Decision Support Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • On-premises
  • Cloud
Applications
  • Drug Allergy Alerts
  • Drug Reminders
  • Drug-drug Interactions
  • Clinical
Companies covered
  • Roche
  • Claricode
  • Philips Healthcare
  • Persivia
  • Cerner
  • Zynx Health
  • Elsevier
  • Epic
  • EPSi/Allscripts
  • Stanson Health
  • Cambio
  • Premier
  • Truven/IBM
  • NDSC/Change
  • MEDITECH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-device Clinical Decision Support Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-device Clinical Decision Support Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Non-device Clinical Decision Support Software Market Dynamics
  1. 2.1 Non-device Clinical Decision Support Software Industry Trends
  2. 2.2 Non-device Clinical Decision Support Software Industry Drivers
  3. 2.3 Non-device Clinical Decision Support Software Industry Opportunities and Challenges
  4. 2.4 Non-device Clinical Decision Support Software Industry Restraints
3 Non-device Clinical Decision Support Software Market by Company
  1. 3.1 Global Non-device Clinical Decision Support Software Company Revenue Ranking in 2025
  2. 3.2 Global Non-device Clinical Decision Support Software Revenue by Company (2021-2026)
  3. 3.3 Global Non-device Clinical Decision Support Software Company Ranking (2024-2026)
  4. 3.4 Global Non-device Clinical Decision Support Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Non-device Clinical Decision Support Software Company Product Type and Application
  6. 3.6 Global Non-device Clinical Decision Support Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Non-device Clinical Decision Support Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Non-device Clinical Decision Support Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Non-device Clinical Decision Support Software Market by Type
  1. 4.1 Non-device Clinical Decision Support Software Type Introduction
  2. 4.1.1 On-premises
  3. 4.1.2 Cloud
  4. 4.2 Global Non-device Clinical Decision Support Software Sales Value by Type
  5. 4.2.1 Global Non-device Clinical Decision Support Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-device Clinical Decision Support Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Non-device Clinical Decision Support Software Sales Value Share by Type (2021-2032)
5 Non-device Clinical Decision Support Software Market by Application
  1. 5.1 Non-device Clinical Decision Support Software Application Introduction
  2. 5.1.1 Drug Allergy Alerts
  3. 5.1.2 Drug Reminders
  4. 5.1.3 Drug-drug Interactions
  5. 5.1.4 Clinical
  6. 5.2 Global Non-device Clinical Decision Support Software Sales Value by Application
  7. 5.2.1 Global Non-device Clinical Decision Support Software Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Non-device Clinical Decision Support Software Sales Value by Application (2021-2032)
  9. 5.2.3 Global Non-device Clinical Decision Support Software Sales Value Share by Application (2021-2032)
6 Non-device Clinical Decision Support Software Regional Value Analysis
  1. 6.1 Global Non-device Clinical Decision Support Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-device Clinical Decision Support Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Non-device Clinical Decision Support Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Non-device Clinical Decision Support Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-device Clinical Decision Support Software Sales Value (2021-2032)
  7. 6.3.2 North America Non-device Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Non-device Clinical Decision Support Software Sales Value (2021-2032)
  10. 6.4.2 Europe Non-device Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Non-device Clinical Decision Support Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Non-device Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Non-device Clinical Decision Support Software Sales Value (2021-2032)
  16. 6.6.2 South America Non-device Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Non-device Clinical Decision Support Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Non-device Clinical Decision Support Software Sales Value Share by Country, 2025 VS 2032
7 Non-device Clinical Decision Support Software Country-level Value Analysis
  1. 7.1 Global Non-device Clinical Decision Support Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-device Clinical Decision Support Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Non-device Clinical Decision Support Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Non-device Clinical Decision Support Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Non-device Clinical Decision Support Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Non-device Clinical Decision Support Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Non-device Clinical Decision Support Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Non-device Clinical Decision Support Software Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Claricode
  8. 8.2.1 Claricode Company Information
  9. 8.2.2 Claricode Business Overview
  10. 8.2.3 Claricode Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Claricode Non-device Clinical Decision Support Software Product Portfolio
  12. 8.2.5 Claricode Recent Developments
  13. 8.3 Philips Healthcare
  14. 8.3.1 Philips Healthcare Company Information
  15. 8.3.2 Philips Healthcare Business Overview
  16. 8.3.3 Philips Healthcare Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Philips Healthcare Non-device Clinical Decision Support Software Product Portfolio
  18. 8.3.5 Philips Healthcare Recent Developments
  19. 8.4 Persivia
  20. 8.4.1 Persivia Company Information
  21. 8.4.2 Persivia Business Overview
  22. 8.4.3 Persivia Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Persivia Non-device Clinical Decision Support Software Product Portfolio
  24. 8.4.5 Persivia Recent Developments
  25. 8.5 Cerner
  26. 8.5.1 Cerner Company Information
  27. 8.5.2 Cerner Business Overview
  28. 8.5.3 Cerner Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cerner Non-device Clinical Decision Support Software Product Portfolio
  30. 8.5.5 Cerner Recent Developments
  31. 8.6 Zynx Health
  32. 8.6.1 Zynx Health Company Information
  33. 8.6.2 Zynx Health Business Overview
  34. 8.6.3 Zynx Health Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zynx Health Non-device Clinical Decision Support Software Product Portfolio
  36. 8.6.5 Zynx Health Recent Developments
  37. 8.7 Elsevier
  38. 8.7.1 Elsevier Company Information
  39. 8.7.2 Elsevier Business Overview
  40. 8.7.3 Elsevier Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Elsevier Non-device Clinical Decision Support Software Product Portfolio
  42. 8.7.5 Elsevier Recent Developments
  43. 8.8 Epic
  44. 8.8.1 Epic Company Information
  45. 8.8.2 Epic Business Overview
  46. 8.8.3 Epic Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Epic Non-device Clinical Decision Support Software Product Portfolio
  48. 8.8.5 Epic Recent Developments
  49. 8.9 EPSi/Allscripts
  50. 8.9.1 EPSi/Allscripts Company Information
  51. 8.9.2 EPSi/Allscripts Business Overview
  52. 8.9.3 EPSi/Allscripts Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EPSi/Allscripts Non-device Clinical Decision Support Software Product Portfolio
  54. 8.9.5 EPSi/Allscripts Recent Developments
  55. 8.10 Stanson Health
  56. 8.10.1 Stanson Health Company Information
  57. 8.10.2 Stanson Health Business Overview
  58. 8.10.3 Stanson Health Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Stanson Health Non-device Clinical Decision Support Software Product Portfolio
  60. 8.10.5 Stanson Health Recent Developments
  61. 8.11 Cambio
  62. 8.11.1 Cambio Company Information
  63. 8.11.2 Cambio Business Overview
  64. 8.11.3 Cambio Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cambio Non-device Clinical Decision Support Software Product Portfolio
  66. 8.11.5 Cambio Recent Developments
  67. 8.12 Premier
  68. 8.12.1 Premier Company Information
  69. 8.12.2 Premier Business Overview
  70. 8.12.3 Premier Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Premier Non-device Clinical Decision Support Software Product Portfolio
  72. 8.12.5 Premier Recent Developments
  73. 8.13 Truven/IBM
  74. 8.13.1 Truven/IBM Company Information
  75. 8.13.2 Truven/IBM Business Overview
  76. 8.13.3 Truven/IBM Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Truven/IBM Non-device Clinical Decision Support Software Product Portfolio
  78. 8.13.5 Truven/IBM Recent Developments
  79. 8.14 NDSC/Change
  80. 8.14.1 NDSC/Change Company Information
  81. 8.14.2 NDSC/Change Business Overview
  82. 8.14.3 NDSC/Change Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 NDSC/Change Non-device Clinical Decision Support Software Product Portfolio
  84. 8.14.5 NDSC/Change Recent Developments
  85. 8.15 MEDITECH
  86. 8.15.1 MEDITECH Company Information
  87. 8.15.2 MEDITECH Business Overview
  88. 8.15.3 MEDITECH Non-device Clinical Decision Support Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 MEDITECH Non-device Clinical Decision Support Software Product Portfolio
  90. 8.15.5 MEDITECH Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst